recombinant expression of monovalent and bivalent anti-tnt-antibodies – evaluation of different expression systems
Clicks: 206
ID: 205016
2008
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
206 views
25 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #91 of 151 articles by views in meditsinskaia radiologiia
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 151 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Monoclonal 11B3 anti-TNT (trinitrotoluene) antibody was expressed as a monovalent and bivalent form using different prokaryotic and eukaryotic expression systems. Recombinant expression in Escherichia coli, mammalian cells and the methylotrophic yeast Pichia pastoris was performed to obtain disulfide-linked and glycosylated antibody forms. The generation of antibody and subsequent evaluation of the expression rates were performed using intracellular, excretory and periplasmatic expression techniques. All methods involved striving for native expressed antibody with maintenance of its functionality only.
| Reference Key |
simonovic2008journalrecombinant
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;BRANISLAV SIMONOVIC;MIROSLAV M. VRVIC;SVETLANA ZLATANOVIC-MILOSEVIC;MLADEN SIMONOVIC |
| Journal | meditsinskaia radiologiia |
| Year | 2008 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.